1.Clinical Outcomes of Surgical Treatments for Traumatic Spinal Injuries due to Snowboarding.
Takahiro MASUDA ; Kei MIYAMOTO ; Kazuhiko WAKAHARA ; Kazu MATSUMOTO ; Akira HIOKI ; Tetsuya SHIMOKAWA ; Katsuji SHIMIZU ; Shinji OGURA ; Haruhiko AKIYAMA
Asian Spine Journal 2015;9(1):90-98
STUDY DESIGN: Retrospective study. PURPOSE: To assess treatment outcomes of snowboarding-related spinal and spinal cord injuries. OVERVIEW OF LITERATURE: Snowboarding-related spinal or spinal cord injury have a great impact on social and sporting activities. METHODS: A retrospective review of 19 cases of surgically treated snowboard-related injury was done. Analyzed parameters included site of injury, type of fracture, peri- and postoperative complications, pre- and postoperative neurological status, activities of daily living, and participation in sports activities at the final follow-up. RESULTS: The major site of injury was the thoracolumbar junction caused by fracture-dislocation (13/19 cases). The remaining 6 cases had cervical spine injuries. Over 60% of the patients had Frankel A and B paralysis. All patients were surgically treated by posterior fusion with instrumentation. Five underwent additional anterior fusion. Surgical outcome was restoration of ambulatory capacity in 12 patients (63.2%). Ultimately, 15 patients (78.9%) could return to work. Patients with complete paralysis upon admission showed reduced ambulatory capacity compared to those with incomplete paralysis. None of the patients again participated in any sports activities, including snowboarding. CONCLUSIONS: Snowboarding-related spinal or spinal cord injury has a great impact on social as well as sports activities. It is necessary to enhance promotion of injury prevention emphasizing the snowboarders' responsibility code.
Activities of Daily Living
;
Follow-Up Studies
;
Humans
;
Paralysis
;
Postoperative Complications
;
Retrospective Studies
;
Return to Work
;
Skiing*
;
Spinal Cord Injuries
;
Spinal Injuries*
;
Spine
;
Sports
2.Single-Stage Removal of Thoracic Dumbbell Tumors from a Posterior Approach Only with Costotransversectomy.
Kei ANDO ; Shiro IMAGAMA ; Norimitsu WAKAO ; Kenichi HIRANO ; Ryoji TAUCHII ; Akio MURAMOTO ; Hiroki MATSUI ; Tomohiro MATSUMOTO ; Yukihiro MATSUYAMA ; Naoki ISHIGURO
Yonsei Medical Journal 2012;53(3):611-617
PURPOSE: Thoracic dumbbell tumors are relatively rare, usually arising from neurogenic elements. Methods for surgical removal thereof remain controversial. The purpose of this study was to evaluate the surgical results of a single-stage posterior approach with laminectomy and costotransversectomy only for the management of thoracic dumbbell tumors. MATERIALS AND METHODS: Eight cases of thoracic large dumbbell tumor were analyzed retrospectively: seven men and one woman (mean age, 49 years). Pathologic findings included schwannoma in five patients, neurofibroma in two patients (Recklinghausen in one patient), and ganglioneuroma in one patient. All patients underwent single-stage removal of dumbbell tumors by a posterior approach followed by laminectomy and costotransversectomy combined with instrumentation. Clinical and radiologic outcomes were reviewed, thereafter. RESULTS: Operative time ranged from 185 to 420 minutes (mean, 313 minutes), with estimated blood loss ranging from 71 to 1830 mL (mean, 658 mL). Postoperative complications included atelectasis in one case. All patients had tumors successfully removed with no neurological deterioration. Spinal deformities were not observed in any patients at the last follow-up (mean, 52 months), with instrumentation. CONCLUSION: Single-stage surgery with laminectomy and costotransversectomy may be useful for removing thoracic dumbbell tumors without a combined anterior approach.
Adolescent
;
Adult
;
Aged
;
Female
;
Humans
;
Laminectomy
;
Male
;
Retrospective Studies
;
Thoracic Neoplasms/*surgery
;
Thoracic Vertebrae/*surgery
3.Variety of the Wave Change in Compound Muscle Action Potential in an Animal Model.
Zenya ITO ; Shiro IMAGAMA ; Kei ANDO ; Akio MURAMOTO ; Kazuyoshi KOBAYASHI ; Tetsuro HIDA ; Kenyu ITO ; Yoshimoto ISHIKAWA ; Mikito TSUSHIMA ; Akiyuki MATSUMOTO ; Satoshi TANAKA ; Masayoshi MOROZUMI ; Yukihiro MATSUYAMA ; Naoki ISHIGURO
Asian Spine Journal 2015;9(6):952-957
STUDY DESIGN: Animal study. PURPOSE: To review the present warning point criteria of the compound muscle action potential (CMAP) and investigate new criteria for spinal surgery safety using an animal model. OVERVIEW OF LITERATURE: Little is known about correlation palesis and amplitude of spinal cord monitoring. METHODS: After laminectomy of the tenth thoracic spinal lamina, 2-140 g force was delivered to the spinal cord with a tension gage to create a bilateral contusion injury. The study morphology change of the CMAP wave and locomotor scale were evaluated for one month. RESULTS: Four different types of wave morphology changes were observed: no change, amplitude decrease only, morphology change only, and amplitude and morphology change. Amplitude and morphology changed simultaneously and significantly as the injury force increased (p<0.05) Locomotor scale in the amplitude and morphology group worsened more than the other groups. CONCLUSIONS: Amplitude and morphology change of the CMAP wave exists and could be the key of the alarm point in CMAP.
Action Potentials*
;
Animals*
;
Contusions
;
Gravitation
;
Laminectomy
;
Models, Animal*
;
Spinal Cord
4.Feasibility, Efficacy, and Predictive Factors for the Technical Success of Endoscopic Nasogallbladder Drainage: A Prospective Study.
Kei YANE ; Hiroyuki MAGUCHI ; Akio KATANUMA ; Kuniyuki TAKAHASHI ; Manabu OSANAI ; Toshifumi KIN ; Ryo TAKAKI ; Kazuyuki MATSUMOTO ; Katsushige GON ; Tomoaki MATSUMORI ; Akiko TOMONARI ; Masanori NOJIMA
Gut and Liver 2015;9(2):239-246
BACKGROUND/AIMS: Several studies have shown the usefulness of endoscopic nasogallbladder drainage (ENGBD) in patients with acute cholecystitis. However, the procedure is difficult, and factors that affect technical success have not yet been clarified. We conducted a prospective study to evaluate the technical feasibility, efficacy, and predictive factors for the technical success of ENGBD in patients with acute cholecystitis. METHODS: All patients with moderate or severe acute cholecystitis who were enrolled underwent ENGBD between April 2009 and April 2011. Patients with surgically altered anatomy or pancreatobiliary malignancies were excluded. The primary outcomes included technical success, clinical success, and complications. Factors that could affect the technical success were also examined. RESULTS: Of the 27 patients who underwent ENGBD during the study period, technical success was achieved in 21 (78%) and clinical improvement was achieved in 20 (95%). Early complications were encountered in four patients (15%). Gallbladder wall thickness (odds ratio [OR], 1.64; 95% confidence interval [CI], 1.08 to 2.47) and age (OR, 1.16; 95% CI, 1.00 to 1.35) were effective predictors of technical failure. CONCLUSIONS: ENGBD was effective in resolving acute cholecystitis; however, this modality was technically challenging and had a limited success rate. Because of technical difficulties, ENGBD should be reserved for limited indications.
Age Factors
;
Aged
;
Aged, 80 and over
;
Cholecystitis, Acute/*surgery
;
Drainage/*methods
;
Endoscopy, Gastrointestinal/*methods
;
Feasibility Studies
;
Female
;
Gallbladder/pathology/*surgery
;
Humans
;
Male
;
Middle Aged
;
Odds Ratio
;
Postoperative Complications/epidemiology
;
Prospective Studies
;
Sphincterotomy, Endoscopic
;
Treatment Outcome
5.Feasibility, Efficacy, and Predictive Factors for the Technical Success of Endoscopic Nasogallbladder Drainage: A Prospective Study.
Kei YANE ; Hiroyuki MAGUCHI ; Akio KATANUMA ; Kuniyuki TAKAHASHI ; Manabu OSANAI ; Toshifumi KIN ; Ryo TAKAKI ; Kazuyuki MATSUMOTO ; Katsushige GON ; Tomoaki MATSUMORI ; Akiko TOMONARI ; Masanori NOJIMA
Gut and Liver 2015;9(2):239-246
BACKGROUND/AIMS: Several studies have shown the usefulness of endoscopic nasogallbladder drainage (ENGBD) in patients with acute cholecystitis. However, the procedure is difficult, and factors that affect technical success have not yet been clarified. We conducted a prospective study to evaluate the technical feasibility, efficacy, and predictive factors for the technical success of ENGBD in patients with acute cholecystitis. METHODS: All patients with moderate or severe acute cholecystitis who were enrolled underwent ENGBD between April 2009 and April 2011. Patients with surgically altered anatomy or pancreatobiliary malignancies were excluded. The primary outcomes included technical success, clinical success, and complications. Factors that could affect the technical success were also examined. RESULTS: Of the 27 patients who underwent ENGBD during the study period, technical success was achieved in 21 (78%) and clinical improvement was achieved in 20 (95%). Early complications were encountered in four patients (15%). Gallbladder wall thickness (odds ratio [OR], 1.64; 95% confidence interval [CI], 1.08 to 2.47) and age (OR, 1.16; 95% CI, 1.00 to 1.35) were effective predictors of technical failure. CONCLUSIONS: ENGBD was effective in resolving acute cholecystitis; however, this modality was technically challenging and had a limited success rate. Because of technical difficulties, ENGBD should be reserved for limited indications.
Age Factors
;
Aged
;
Aged, 80 and over
;
Cholecystitis, Acute/*surgery
;
Drainage/*methods
;
Endoscopy, Gastrointestinal/*methods
;
Feasibility Studies
;
Female
;
Gallbladder/pathology/*surgery
;
Humans
;
Male
;
Middle Aged
;
Odds Ratio
;
Postoperative Complications/epidemiology
;
Prospective Studies
;
Sphincterotomy, Endoscopic
;
Treatment Outcome
6.Progressive Relapse of Ligamentum Flavum Ossification Following Decompressive Surgery.
Kei ANDO ; Shiro IMAGAMA ; Zenya ITO ; Kazuyoshi KOBAYASHI ; Junichi UKAI ; Akio MURAMOTO ; Ryuichi SHINJO ; Tomohiro MATSUMOTO ; Hiroaki NAKASHIMA ; Naoki ISHIGURO
Asian Spine Journal 2014;8(6):835-839
Thoracic ossification of the ligamentum flavum (T-OLF) is a relatively rare spinal disorder that generally requires surgical intervention, due to its progressive nature and the poor response to conservative therapy. The prevalence of OLF has been reported at 3.8%-26%, which is similar to that of cervical ossification of the posterior longitudinal ligament (OPLL). The progression of OPLL after cervical laminoplasty for the treatment of OPLL is often shown in long-term follow-up. However, there have been no reports on the progression of OLF following surgery. We report a case of thoracic myelopathy secondary to the progressive relapse of OLF following laminectomy.
Follow-Up Studies
;
Laminectomy
;
Ligamentum Flavum*
;
Longitudinal Ligaments
;
Prevalence
;
Recurrence*
;
Spinal Cord Diseases
7.A Prospective Multicenter Study Evaluating Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Prescribed Antithrombotic Agents.
Kazumichi KAWAKUBO ; Kei YANE ; Kazunori ETO ; Hirotoshi ISHIWATARI ; Nobuyuki EHIRA ; Shin HABA ; Ryusuke MATSUMOTO ; Keisuke SHINADA ; Hiroaki YAMATO ; Taiki KUDO ; Manabu ONODERA ; Toshinori OKUDA ; Yoko TAYA-ABE ; Shuhei KAWAHATA ; Kimitoshi KUBO ; Yoshimasa KUBOTA ; Masaki KUWATANI ; Hiroshi KAWAKAMI ; Akio KATANUMA ; Michihiro ONO ; Tsuyoshi HAYASHI ; Minoru UEBAYASHI ; Naoya SAKAMOTO
Gut and Liver 2018;12(3):353-359
BACKGROUND/AIMS: Although the risk of bleeding after endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is low, the safety of EUS-FNA in patients prescribed antithrom-botic agents is unclear. Therefore, this study evaluated the incidence of bleeding after EUS-FNA in those patients. METHODS: Between September 2012 and September 2015, patients who were prescribed antithrombotic agents underwent EUS-FNA at 13 institutions in Japan were prospectively enrolled in the study. The antithrombotic agents were managed according to the guidelines of the Japanese Gastrointestinal Endoscopy Society. The rate of bleeding events, thromboembolic events and other complications within 2 weeks after EUS-FNA were analyzed. RESULTS: Of the 2,629 patients who underwent EUS-FNA during the study period, 85 (62 males; median age, 74 years) patients were included in this stduy. Two patients (2.4%; 95% confidence interval [CI], 0.6% to 8.3%) experienced bleeding events. One patient required surgical intervention for hemothorax 5 hours after EUS-FNA, and the other experienced melena 8 days after EUS-FNA and required red blood cell transfusions. No thromboembolic events occurred (0%; 95% CI, 0.0% to 4.4%). Three patients (3.5%; 95% CI, 1.2% to 10.0%) experienced peri-puncture abscess formation. CONCLUSIONS: The rate of bleeding after EUS-FNA in patients prescribed antithrombotic agents might be considerable.
Abscess
;
Asian Continental Ancestry Group
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration*
;
Endoscopy, Gastrointestinal
;
Erythrocyte Transfusion
;
Fibrinolytic Agents*
;
Hemorrhage*
;
Hemothorax
;
Humans
;
Incidence
;
Japan
;
Male
;
Melena
;
Prospective Studies*
8.Clinical Impact of Different Reconstruction Methods on Remnant Gastric Cancer at the Anastomotic Site after Distal Gastrectomy
Kei MATSUMOTO ; Shinwa TANAKA ; Takashi TOYONAGA ; Nobuaki IKEZAWA ; Mari NISHIO ; Masanao URAOKA ; Tomoatsu YOSHIHARA ; Hiroya SAKAGUCHI ; Hirofumi ABE ; Tetsuya YOSHIZAKI ; Madoka TAKAO ; Toshitatsu TAKAO ; Yoshinori MORITA ; Hiroshi YOKOZAKI ; Yuzo KODAMA
Clinical Endoscopy 2022;55(1):86-94
Background/Aims:
The anastomotic site after distal gastrectomy is the area most affected by duodenogastric reflux. Different reconstruction methods may affect the lesion characteristics and treatment outcomes of remnant gastric cancers at the anastomotic site. We retrospectively investigated the clinicopathologic and endoscopic submucosal dissection outcomes of remnant gastric cancers at the anastomotic site.
Methods:
We recruited 34 consecutive patients who underwent endoscopic submucosal dissection for remnant gastric cancer at the anastomotic site after distal gastrectomy. Clinicopathology and treatment outcomes were compared between the Billroth II and non-Billroth II groups.
Results:
The tumor size in the Billroth II group was significantly larger than that in the non-Billroth II group (22 vs. 19 mm; p=0.048). More severe gastritis was detected endoscopically in the Billroth II group (2 vs. 1.33; p=0.0075). Moreover, operation time was longer (238 vs. 121 min; p=0.004) and the frequency of bleeding episodes was higher (7.5 vs. 3.1; p=0.014) in the Billroth II group.
Conclusions
Compared to remnant gastric cancers in non-Billroth II patients, those in the Billroth II group had larger lesions with a background of severe remnant gastritis. Endoscopic submucosal dissection for remnant gastric cancers in Billroth II patients involved longer operative times and more frequent bleeding episodes than that in patients without Billroth II.
9.Study protocol of the Asian XELIRI ProjecT (AXEPT):a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the effcacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab
Kotaka MASAHITO ; Xu RUIHUA ; Muro KEI ; Park Suk YOUNG ; Morita SATOSHI ; Iwasa SATORU ; Uetake HIROYUKI ; Nishina TOMOHIRO ; Nozawa HIROAKI ; Matsumoto HIROSHI ; Yamazaki KENTARO ; Han SAE-WON ; Wang WEI ; Ahn Bae JOONG ; Deng YANHONG ; Cho SANG-HEE ; YiBa ; Lee KEUN-WOOK ; Zhang TAO ; Satoh TAROH ; E.Buyse MARC ; Ryoo BAEK-YEOL ; Shen LIN ; Sakamoto JUNICHI ; Kim Won TAE
Chinese Journal of Cancer 2016;35(12):735-742
Background:Capecitabine and irinotecan combination therapy (XELIRI) has been examined at various dose levels to treat metastatic colorectal cancer (mCRC). Recently, in the Association of Medical Oncology of the German Cancer Society (AIO) 0604 trial, tri?weekly XELIRI plus bevacizumab, with reduced doses of irinotecan (200mg/m2 on day 1) and capecitabine (1600mg/m2 on days 1–14), repeated every 3weeks, has shown favorable tolerability and effcacy which were comparable to those of capecitabine and oxaliplatin (XELOX) plus bevacizumab. The doses of capecit?abine and irinotecan in the AIO trial are considered optimal. In a phase I/II study, XELIRI plus bevacizumab (BIX) as second?line chemotherapy was well tolerated and had promising effcacy in Japanese patients. Methods:The Asian XELIRI ProjecT (AXEPT) is an East Asian collaborative, open?labelled, randomized, phase III clinical trial which was designed to demonstrate the non?inferiority of XELIRI with or without bevacizumab versus standard FOLFIRI (5?lfuorouracil, leucovorin, and irinotecan combination) with or without bevacizumab as second?line chemo?therapy for patients with mCRC. Patients with 20years of age or older, histologically conifrmed mCRC, Eastern Coop?erative Oncology Group performance status 0–2, adequate organ function, and disease progression or intolerance of the ifrst?line regimen will be eligible. Patients will be randomized (1:1) to receive standard FOLFIRI with or with?out bevacizumab (5mg/kg on day 1), repeated every 2weeks (FOLIRI arm) or XELIRI with or without bevacizumab (7.5mg/kg on day 1), repeated every 3weeks (XELIRI arm). A total of 464 events were estimated as necessary to show non?inferiority with a power of 80% at a one?sided α of 0.025, requiring a target sample size of 600 patients. The 95% conifdence interval (CI) upper limit of the hazard ratio was pre?speciifed as less than 1.3. Conclusion:The Asian XELIRI ProjecT is a multinational phase III trial being conducted to provide evidence for XELIRI with or without bevacizumab as a second?line treatment option of mCRC.